Coherus BioSciences Set to Shine at Healthcare Conference
Coherus BioSciences, Inc. (NASDAQ: CHRS), recognized for its innovative contributions to biotechnology, has confirmed that its senior management will be attending the highly anticipated 2024 Citi Global Healthcare Conference. This event presents a prime opportunity for industry leaders to share insights, network, and discuss groundbreaking developments in healthcare.
Key Speaker to Lead Panel Discussion
At the conference, Dr. Theresa LaVallee, the Chief Development Officer of Coherus, will be taking the stage to participate in a significant panel discussion titled "Novel Mechanisms in Oncology." This anticipated session is scheduled for December 3, 2024, at 3:15 p.m. ET, and is expected to attract attention from various stakeholders within the industry.
Overview of the Oncology Panel
The oncology panel will focus on cutting-edge advancements and innovative approaches in cancer treatment, a critical area of research within biotechnology. Dr. LaVallee’s participation signifies Coherus's commitment to leading the charge in oncology and supporting the scientific community’s understanding of novel therapeutic mechanisms.
This panel discussion is not only valuable for investors but also aims to engage healthcare professionals, policy makers, and researchers who are keen to explore the evolving landscape of oncology research and treatment options.
Investment and Corporate Engagement
Such events are instrumental for Coherus as they present opportunities for investment discussions and fostering potential collaborations. Engaging with the investor community helps illuminate the company’s strategic direction and growth momentum, reinforcing its position in the biotechnology sector.
Importance of Webcast Access
For interested parties unable to attend in person, the panel discussion will be accessible via a webcast. This ensures that the insights shared can reach a broader audience interested in Coherus's developments and contributions to oncology.
Contacting Coherus for More Information
For those seeking further information on the conference or the company's latest initiatives, Coherus encourages direct inquiries. Jodi Sievers, VP of Investor Relations & Corporate Communications, is available to address any questions or provide detailed insights into the company’s participation at the conference.
How to Reach Out
Interested investors and stakeholders can connect with Jodi Sievers via email at IR@coherus.com for additional information regarding investor relations or to discuss specific inquiries about company developments.
Frequently Asked Questions
What is the Citi Global Healthcare Conference?
The Citi Global Healthcare Conference is a premier event where industry leaders discuss current trends and innovations in the healthcare sector.
Who is representing Coherus at the conference?
Dr. Theresa LaVallee, the Chief Development Officer of Coherus BioSciences, will represent the company at the conference.
What topics will be discussed at the oncology panel?
The oncology panel will address novel mechanisms in cancer therapies and the latest advances in oncology research.
Will the panel discussion be available to the public?
Yes, the panel will be accessible via a live webcast for those who cannot attend in person.
How can investors contact Coherus for more information?
Investors can reach out to Jodi Sievers at IR@coherus.com for further inquiries regarding the company's activities and investor relations.
